Jennifer J Rhodes Angion Biomedica Corp. (ANGN) insider trading activity

Jennifer J Rhodes is Officer of Angion Biomedica Corp.. Currently has a direct ownership of 30,399 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2021, when has been sold 451 shares (Common Stock) at a price of $2.42 per share, resulting in proceeds of $1,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K

0% 3M change

0% 12M change

Total Value Held $0

Jennifer J Rhodes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2021	SELL Open market or private sale	$1,091 $2.42 p/Share	451 Reduced 1.46%	30,399 Common Stock
Nov 15 2021	SELL Open market or private sale	$1,905 $4.4 p/Share	433 Reduced 1.38%	30,850 Common Stock
Oct 14 2021	SELL Open market or private sale	$3,719 $8.65 p/Share	430 Reduced 1.36%	31,283 Common Stock
Sep 14 2021	SELL Open market or private sale	$4,575 $10.64 p/Share	430 Reduced 1.34%	31,713 Common Stock
Aug 16 2021	SELL Open market or private sale	$4,753 $10.68 p/Share	445 Reduced 1.37%	32,143 Common Stock
Jul 21 2021	SELL Open market or private sale	$4,726 $10.94 p/Share	432 Reduced 1.31%	32,588 Common Stock
Jul 14 2021	SELL Open market or private sale	$4,745 $11.01 p/Share	431 Reduced 1.31%	32,589 Common Stock
Jun 14 2021	SELL Open market or private sale	$5,666 $13.27 p/Share	427 Reduced 1.28%	33,020 Common Stock
May 14 2021	SELL Open market or private sale	$6,125 $13.92 p/Share	440 Reduced 1.3%	33,447 Common Stock
Apr 15 2021	SELL Open market or private sale	$5,989 $15.01 p/Share	399 Reduced 1.16%	33,887 Common Stock
Mar 13 2021	SELL Open market or private sale	$10,205 $20.45 p/Share	499 Reduced 1.43%	34,286 Common Stock
Feb 13 2021	SELL Open market or private sale	$8,930 $19.54 p/Share	457 Reduced 1.3%	34,785 Common Stock

Also insider at

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

EVP, CHIEF LEGAL OFFICER, SEC

JJR